Harnessing Stem Cells for Pediatric Respiratory Diseases: Potential and Clinical Translation DOI

Fatemeh Alizadeh,

Sanaz Yasrebinia

Cell Biology International, Год журнала: 2025, Номер unknown

Опубликована: Май 30, 2025

ABSTRACT Pediatric respiratory diseases, ranging from acute infections to chronic lung conditions, pose significant morbidity and mortality risks. Current treatment approaches focus on symptomatic relief rather than regenerative solutions. Stem cell therapy has emerged as a promising alternative due its potential for immunomodulation, inflammation reduction, tissue repair. Mesenchymal stem cells (MSCs) induced pluripotent (iPSCs) have been extensively studied their properties, with MSC‐derived extracellular vesicles showing cell‐free therapeutic approach. Despite preclinical early clinical findings, challenges such immune rejection, ethical concerns, the need standardized protocols hinder translation. This review examines recent advancements in pediatric outlining potential, limitations, future research directions.

Язык: Английский

Novel therapeutic approaches for non-small cell lung cancer: an updated view DOI

Niloufar Orooji,

Shabnam Babaei,

Manouchehr Fadaee

и другие.

Journal of drug targeting, Год журнала: 2025, Номер unknown, С. 1 - 29

Опубликована: Апрель 5, 2025

Non-small cell lung cancer (NSCLC) continues to be one of the leading causes cancer-related mortality globally. Most patients who undergo surgical procedures may encounter distant metastasis or local recurrence, necessitating supplementary treatments such as radiation therapy, chemotherapy, targeted therapy adjuvant alternatives. Recent advancements in molecular biology and immunotherapy have paved way for innovative therapeutic approaches that target specific genetic mutations promote immune response against tumor cells. This review explores emerging therapies, including therapies tyrosine kinase inhibitors (TKIs) actionable (e.g., EGFR, ALK, ROS1), well role checkpoint (ICIs) employ body's system combat cancer. Additionally, we discuss potential exosome promising nanotherapeutic options treatment NSCLC. study attempts provide a thorough overview changing landscape NSCLC its implications enhancing patient outcomes by presenting these techniques.

Язык: Английский

Процитировано

3

Cell-based Immunotherapy in Esophageal Cancer DOI
Masoud Lahouty,

Amirhossein Soleymanzadeh,

Sohrab Kazemi

и другие.

Journal of drug targeting, Год журнала: 2025, Номер unknown, С. 1 - 19

Опубликована: Март 10, 2025

Esophageal cancer (EC) is among the most common illnesses globally, and its prognosis unfavorable. Surgery, radiotherapy, chemotherapy are primary therapy options for EC. Despite occasional efficacy of these traditional treatment modalities, individuals with EC remain at a significant risk local recurrence metastasis. Consequently, innovative efficacious medicines required. In recent decades, clinical practice has effectively implemented cell therapy, which includes both stem non-stem cell-based approaches, as an tumor treatment, offering renewed hope to patients esophageal squamous carcinoma (ESCC). This paper examines theoretical framework contemporary advancements in We further described current studies summarized essential data related survival safety assessments.

Язык: Английский

Процитировано

2

Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets DOI Open Access

Miguel L. Rufail,

Rosaria Bassi, Paola Giussani

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(3), С. 1056 - 1056

Опубликована: Янв. 26, 2025

Cancer biology revolves around understanding how cells undergo uncontrolled proliferation leading to the formation of malignant tumors. Key aspects include self-sufficiency in growth signals, lack response signals inhibition, evasion apoptosis, sustained angiogenesis, immune response, capacity invade and metastasize, alterations cellular metabolism. A vast amount research, which is exponentially growing, over past few decades highlights role sphingolipids cancer. They act not only as structural membrane components but also bioactive molecules that regulate cell fate different physio-pathological conditions. In cancer, sphingolipid metabolism dysregulated, contributing tumor progression, metastasis, drug resistance. this review, we outline impact sphingosine-1-phosphate (S1P) a key We give an overview its summarizing S1P intracellular extracellular mediator through specific plasma receptors cancers. describe previous findings on disruption balance between ceramide (Cer) common cancer can contribute tumorigenesis resistance chemotherapy. finally consider potential targeting metabolic pathways well transporters promising therapeutic approach treatments.

Язык: Английский

Процитировано

1

Plant Terpenoids in Combination with Conventional Therapeutics in Colorectal Cancer: A Promising Option DOI
Chengu Niu, Jing Zhang, Patrick Okolo

и другие.

Current Oncology Reports, Год журнала: 2025, Номер unknown

Опубликована: Апрель 21, 2025

Язык: Английский

Процитировано

0

The effects of n-3 PUFAs on colorectal cancer carcinogenesis: comprehensive review DOI Creative Commons
Manouchehr Fadaee, Masoud Lahouty, Morteza Abdi

и другие.

Food and Agricultural Immunology, Год журнала: 2025, Номер 36(1)

Опубликована: Май 15, 2025

Язык: Английский

Процитировано

0

Gut microbiome and Colorectal Cancer: from pathogenesis to treatment DOI
Masoud Lahouty, Manouchehr Fadaee,

Reza Aghaei

и другие.

Pathology - Research and Practice, Год журнала: 2025, Номер 271, С. 156034 - 156034

Опубликована: Май 21, 2025

Язык: Английский

Процитировано

0

Anti-infertility roles of flavonoids: insights into the female reproductive system DOI
Morteza Abdi, Hadi Karimzadeh, Amirreza jourabchi

и другие.

Molecular Biology Reports, Год журнала: 2025, Номер 52(1)

Опубликована: Май 22, 2025

Язык: Английский

Процитировано

0

Clostridium difficile as a potent trigger of colorectal carcinogenesis DOI Creative Commons
Javad Nezhadi, Masoud Lahouty, Mohammad Ahangarzadeh Rezaee

и другие.

Discover Oncology, Год журнала: 2025, Номер 16(1)

Опубликована: Май 24, 2025

Язык: Английский

Процитировано

0

Harnessing Stem Cells for Pediatric Respiratory Diseases: Potential and Clinical Translation DOI

Fatemeh Alizadeh,

Sanaz Yasrebinia

Cell Biology International, Год журнала: 2025, Номер unknown

Опубликована: Май 30, 2025

ABSTRACT Pediatric respiratory diseases, ranging from acute infections to chronic lung conditions, pose significant morbidity and mortality risks. Current treatment approaches focus on symptomatic relief rather than regenerative solutions. Stem cell therapy has emerged as a promising alternative due its potential for immunomodulation, inflammation reduction, tissue repair. Mesenchymal stem cells (MSCs) induced pluripotent (iPSCs) have been extensively studied their properties, with MSC‐derived extracellular vesicles showing cell‐free therapeutic approach. Despite preclinical early clinical findings, challenges such immune rejection, ethical concerns, the need standardized protocols hinder translation. This review examines recent advancements in pediatric outlining potential, limitations, future research directions.

Язык: Английский

Процитировано

0